RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS

RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS

The review focuses on respiratory syncytial virus infection (RSVI) and, based on the literature and authors' own observations, highlights epidemiological aspects and risk factors for RSVI (including severe forms of the infection), the specific clinical manifestations, challenges of laboratory d...

Full description

Bibliographic Details
Main Authors:	K. V. YEVDOKIMOV, V. B. ROVNIY, I. V. BABACHENKO, E. V. SHARIPOVA
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-05-01
Series:	Медицинский совет
Subjects:	respiratory syncytial virus infection children severe course risk groups laboratory diagnosis prevention palivizumab.
Online Access:	https://www.med-sovet.pro/jour/article/view/1843

Similar Items

Patient equity and respiratory syncytial virus Immunoprophylaxis
by: H. Cody Meissner
Published: (2019-01-01)

Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil
by: Roseane Porfírio de Souza, et al.
Published: (2019-08-01)

Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era
by: Bernhard Resch, et al.
Published: (2017-04-01)

One‐year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America
by: Leandro Martin Castillo, et al.
Published: (2017-09-01)

Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?
by: Alessandro Rocca, et al.
Published: (2021-04-01)

Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
by: Piedimonte Giovanni
Published: (2002-06-01)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
by: Kimpen Jan LL
Published: (2002-06-01)

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS
by: A. A. Baranov, et al.
Published: (2012-12-01)

IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM
by: A. A. Korsunskiy, et al.
Published: (2012-06-01)

Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
by: André Ricardo Ribas Freitas, et al.
Published: (2016-01-01)

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Detection of the Onset of the Epidemic Period of Respiratory Syncytial Virus Infection in Japan
by: Hidetomi Yamagami, et al.
Published: (2019-03-01)

Respiratory syncytial virus infection in children with congenital heart defects: Problem relevance and prevention guidelines
by: E. L. Bockeria, et al.
Published: (2016-03-01)

Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use
by: Silva Camila de A, et al.
Published: (2012-05-01)

Immunoprophylaxis of respiratory syncytial virus: global experience
by: Simoes Eric AF
Published: (2002-06-01)

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
by: Jesse Papenburg, et al.
Published: (2012-01-01)

A CLINICAL AND ECONOMICAL ANALYSIS OF THE RESULTS PRODUCED BY THE PROGRAM OF RSV-INFECTION PROPHYLAXIS DURING THE EPIDEMIOLOGICAL SEASON OF 2012/2013 IN MOSCOW
by: V. I. Ignat'eva, et al.
Published: (2013-11-01)

IMMUNE PREVENTION OF RESPIRATORY-SYNCYTIAL VIRAL INFECTION: 15 YEARS OF WORLD EXPERIENCE
by: E. S. Keshishyan
Published: (2013-07-01)

Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada
by: Rodica Gilca, et al.
Published: (2020-12-01)

ACUTE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN IN THE AGE ASPECT
by: V. B. Rovny, et al.
Published: (2015-08-01)

Palivizumab e virus respiratorio sinciziale: una panoramica
by: Paolo Manzoni
Published: (2011-07-01)

Survival of recombinant monoclonal and naturally-occurring human milk immunoglobulins A and G specific to respiratory syncytial virus F protein across simulated human infant gastrointestinal digestion
by: Jiraporn Lueangsakulthai, et al.
Published: (2020-10-01)

Modern Approaches in management of Children with Acute Bronchiolitis
by: Alexander A. Baranov, et al.
Published: (2020-02-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Respiratory syncytial virus groups A and B in Porto Alegre, Brazil, from 1990 to 1995 and 1998
by: Straliotto Selir M, et al.
Published: (2001-01-01)

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN THE FIRST YEAR OF LIFE
by: I. V. Babachenko, et al.
Published: (2018-10-01)

Bronchiolitis - diagnostic and therapeutic difficulties in pediatric patients
by: Iwona Kowalska, et al.
Published: (2020-03-01)

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
by: Antonino Capizzi, et al.
Published: (2017-08-01)

Respiratory Syncytial Virus Lower Respiratory Tract Infections in Premature Infants and Infants with Bronchopulmonary Dysplasia
by: D. Yu. Ovsyannikov, et al.
Published: (2015-10-01)

Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
by: Ralph Schmidt, et al.
Published: (2017-12-01)

Laboratory diagnostics acute respiratory virus infections under evolutionary variability influenza viruses
by: V. F. Suhovetskaya, et al.
Published: (2014-09-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012-07-01)

Loop mediated isothermal amplification to detect respiratory syncytial virus in respiratory specimens
by: Hart, Dirk
Published: (2015)

Respiratory syncytial virus (RSV) in infants hospitalized for acute lower respiratory tract disease: incidence and associated risks
by: Adriana Gut Lopes Riccetto, et al.

Respiratory Syncytial Virus Infection in Homeless Populations, Washington, USA
by: Jim Boonyaratanakornkit, et al.
Published: (2019-07-01)

Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA/IgA) in an Ex Vivo Infant Digestion Model
by: Jiraporn Lueangsakulthai, et al.
Published: (2020-02-01)

Prevalence and clinical aspects of respiratory syncytial virus A and B groups in children seen at Hospital de Clínicas of Uberlândia, MG, Brazil
by: TFM Oliveira, et al.
Published: (2008-08-01)

Immune response to respiratory syncytial virus infection (<i>Orthopneumovirus</i>)
by: A. A. Nikonova, et al.
Published: (2021-03-01)

Respiratory syncytial virus infection in a selected sample of infants hospitalized for lower respiratory tract infection in Lithuania and Estonia
by: Nijolė Drazdienė, et al.
Published: (2018-01-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION: CLINICAL AND LABORATORY FEATURES
by: E. V. Mikhaylova, et al.
Published: (2017-07-01)

Cannot write session to /tmp/vufind_sessions/sess_099ivjims0et8obve46tv5c3i1